Sélectionner la langue
Coagulation factor IX
Coagulation factor IX Informations sur la molécule
| Nom anglais | Coagulation factor IX | Nombre de médicaments commercialisés | 34 |
| Nombre de médicaments cliniques | 23 | Alias de la cible | Coagulation Factor IX，Plasma Thromboplastin Component，Christmas Factor，Christmas Disease，Factor IX F9，Hemophilia B，EC 3.4.21.22，F9 P22，THPH8，HEMB，FIX，P19，Factor IX，EC:3.4.21.22，F9，PTC，EC 3.4.21，Plasma Thromboplastic Component，Factor 9 |
| Phase de R&D la plus avancée | Approved | ||
| Nom anglais | Coagulation factor IX |
| Alias de la cible | Coagulation Factor IX，Plasma Thromboplastin Component，Christmas Factor，Christmas Disease，Factor IX F9，Hemophilia B，EC 3.4.21.22，F9 P22，THPH8，HEMB，FIX，P19，Factor IX，EC:3.4.21.22，F9，PTC，EC 3.4.21，Plasma Thromboplastic Component，Factor 9 |
| Nombre de médicaments commercialisés | 34 |
| Nombre de médicaments cliniques | 23 |
| Phase de R&D la plus avancée | Approved |
Coagulation factor IX Liste de produits
- Attribut
Protein (2)
- Bibliothèque de produits
En ligne (2)
- Espèces
Cynomolgus (1)Human (1)
- Étiquette
His Tag (2)
- Marqueur
Unconjugated (2)
| Numéro de produit | Espèces | Système d'expression | Description du produit | Structure protéique | Pureté | Caractéristiques | Pré-commande/Commande |
|---|---|---|---|---|---|---|---|
FIX-H52H3 |  Human | HEK293 | Human Coagulation factor IX / F9 Protein, His Tag, low endotoxin (Pro-form, MALS verified) |  |  |  Ajouter au panier | |
FIX-C52H9 |  Cynomolgus | HEK293 | Cynomolgus Coagulation factor IX / F9 Protein, His Tag (Pro-form, MALS verified) |  | | Ajouter au panier |
Quantité totale2
- 1
Coagulation factor IXContexte de la molécule
Coagulation Factor IX is also known as F9, FIX, and P19. Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca2+ ions, phospholipids, and factor VIIIa，and plays an important role in the intrinsic blood coagulation cascade. As a key component of the clotting cascade, Factor IX helps form stable blood clots and prevents excessive bleeding.
Coagulation factor IXAlias de la molécule
Coagulation factor Ix,PTC,F9,THPH8,FIX,Plasma Thromboplastic Component,factor Ix
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Denecimig | NNC0365-3769 A; NN0365-3769; NN 7769; Mim-8; NNC0365-3769; NN7769; NN-7769; Mim8 | Phase 3 Clinical | Novo Nordisk A/S | Hemophilia A | Details |
| Human prothrombin complex (National Drug Group Wuhan Blood) | Phase 3 Clinical | Sinopharm Wuhan Biopharmaceutical Co Ltd | Hemophilia B; Hemorrhage | Details | |
| Eptacog Alfa Biosimilar(Aryogen Pharmed) | Phase 3 Clinical | Aryogen Pharmed Co | Factor VII Deficiency; Hemophilia A | Details | |
| Human prothrombin complex concentrate (Sichuan Yuanda Shuyang Pharmaceutical) | Phase 3 Clinical | Yuanda Shuyang Life Sciences (Chengdu) Co Ltd | Blood Coagulation Disorders | Details | |
| Arvenacogene Sanparvovec | ANB-002; ANB-2 | Phase 3 Clinical | BIOCAD JSC | Hemophilia B | Details |
| Human prothrombin complex concentrate (Harbin Shiheng Bioengineering Pharmaceutical) | Phase 3 Clinical | Harbin Pacific Biopharmaceutical Co Ltd | Hemophilia B | Details | |
| Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical) | Phase 3 Clinical | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | Hemophilia B | Details | |
| aPCC-emicizumab | Phase 3 Clinical | Emory University | Hemophilia A | Details | |
| BAX-335 | BAX-335; AskBio-009 | Phase 2 Clinical | AskBio Inc, Bayer AG, Glaxosmithkline Plc | Hemophilia B | Details |
| Factor VIIa-CTP | MOD-5014; MOD-5017; OPK88005 | Phase 2 Clinical | Opko Health Inc, Prolor Biotech | Blood Coagulation Disorders, Inherited; Hemophilia A; Hemophilia B | Details |
| REGV131-LNP1265 | REGV131-LNP1265 | Phase 2 Clinical | Intellia Therapeutics Inc, Regeneron Pharmaceuticals Inc | Hemophilia B | Details |
| BE-101 | BE-101 | Phase 2 Clinical | Be Biopharma Inc | Hemophilia B | Details |
| SR-604 | SR-604; SR604 | Phase 2 Clinical | Shanghai Raas Blood Products Co Ltd | Factor VII Deficiency; Hemophilia A; Hemophilia B; Hemorrhage; von Willebrand Diseases | Details |
| FT-004 | FT-004; FT004 | Phase 2 Clinical | Frontera Therapeutics (Shanghai) Co Ltd | Hematologic Diseases; Hemophilia B | Details |
| ZS-801 | ZS801; ZS-801 | Phase 2 Clinical | Sichuan Real&Best Biotech Co Ltd | Hemophilia B | Details |
| VGB-R04 | VGB-R04 | Phase 2 Clinical | Shanghai Vitalgen BioPharma Co Ltd | Hemophilia B | Details |
| Eptacog alfa biosimilar (Valin Technologies) | Phase 1 Clinical | Valin Technologies | Hemophilia A | Details | |
| AAV2-hFIX16 | AAV2-hFIX16 | Phase 1 Clinical | Spark Therapeutics Inc | Hemophilia B | Details |
| SS-327 | GenSciences-327; 注射用培重组人凝血因子IX-Fc融合蛋白; SS327 | Phase 1 Clinical | Furen Pharmaceutical Group Co Ltd, Zhengzhou Shengsi Biotechnology Co Ltd | Hemophilia B | Details |
| NTB-001 | NTB-001 | Phase 1 Clinical | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Hemophilia A | Details |
| Emicizumab biosimilar (Wuhan Yzy Biopharma) | Y225 | Phase 1 Clinical | Wuhan Yzy Biopharma Co Ltd | Hemophilia A; Hemorrhage | Details |
| JWK-004 | JWK004; JWK-004 | Phase 1 Clinical | Chengdu Genevector Biotechnology Co Ltd | Hemophilia B | Details |
| YUVA-GT-F901 | YUVA-GT-F901 | Phase 1 Clinical | Novartis Pharma Ag | Hemophilia B | Details |
Informations sur les médicaments commercialisés
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Plus ancien nom de marque | Pays d'approbation le plus ancien | Indication la plus ancienne | Société d'approbation la plus ancienne | Date d'approbation la plus ancienne | Indication | Essai clinique |
|---|---|---|---|---|---|---|---|---|---|---|
| Anti-inhibitor coagulant complex (Baxalta) | Approved | Baxalta Incorporated | PROPLEX 600, Prothromplex, Prothromplex 600, Prothromplex 600 IE, Prothromplex 600 SV, Prothromplex 600 TV, Prothromplex 600 UI, Prothromplex NF 600, PROPLEX, Feiba, Prothromplex TOTAL | United States | Hemophilia B; Hemophilia A | Baxalta Incorporated | 1979-12-21 | Blood Coagulation Disorders; Blood Coagulation Disorders, Inherited; Cardiovascular Diseases; Heart Diseases; Hemophilia A; Hemophilia B; Hemorrhage | Details | |
| Human prothrombin complex (Nanyue Biopharming) | Approved | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | Mainland China | Hemorrhage | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | 2019-09-05 | Hemophilia B; Hemorrhage | Details | ||
| Eptacog alfa (Novo Nordisk) | NN-007 | Approved | Novo Nordisk A/S | NiaStase, NovoSeven, 诺其 | EU | Thrombasthenia; Factor VII Deficiency; Hemophilia A; Hemophilia B | Novo Nordisk A/S | 1996-02-23 | Acquired hemophilia; Blood Loss, Surgical; Burns; Cerebral Hemorrhage; Factor VII Deficiency; Hemophilia A; Hemophilia B; Hemorrhage; Liver Cirrhosis; Postpartum Hemorrhage; Severe Dengue; Spinal Diseases; Stroke; Thrombasthenia; Wounds and Injuries | Details |
| Etranacogene dezaparvovec | AMT-060; AAV5-hFIX; AMT-061; CSL-222; AAV5-FIX; CSL-220 | Approved | Uniqure Biopharma Bv | HEMGENIX | United States | Hemophilia B | Csl Behring | 2022-11-22 | Hemophilia B | Details |
| Human prothrombin complex (CSL Behring) | BE-1116 | Approved | Csl Behring Llc | Kcentra, Beriplex, Confidex | Japan | Vitamin K Deficiency Bleeding | Csl Behring Kk | Blood Coagulation Disorders; Coagulation Protein Disorders; Heart Diseases; Heart Failure; Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Vitamin K Deficiency Bleeding; Wounds and Injuries | Details | |
| Freeze-dried activated human blood coagulation factor Ⅶ concentrate containing factor Ⅹ (Kaketsuken/KM Biologics) | MC-710 | Approved | KM Biologics Co Ltd | Byclot | Japan | Hemophilia A | KM Biologics Co Ltd | 2014-07-04 | Hemophilia A | Details |
| Human prothrombin complex concentrate (Guizhou Taibang Biological Products) | Approved | Guizhou Taibang Biological Products Co Ltd | Mainland China | Hypoprothrombinemias | Guizhou Taibang Biological Products Co Ltd | 2013-07-31 | Hypoprothrombinemias | Details | ||
| Prothrombinex-VF (CSL Behring) | Approved | Csl Behring Llc | Australia | Hemorrhage | Csl Behring Llc | 2014-10-01 | Hemorrhage | Details | ||
| Fidanacogene elaparvovec | SPK-9001; PF-06838435 | Approved | Childrens Hospital of Philadelphia | BEQVEZ, DURVEQTIX | Canada | Hemophilia B | Pfizer Inc | 2024-01-03 | Hemophilia A; Hemophilia B | Details |
| Prothrombin complex concentrate (Sanquin) | Approved | Sanquin Plasma Products Bv | Cofact | Hemorrhage | Sanquin Plasma Products Bv | 2007-11-01 | Hemorrhage | Details | ||
| Emicizumab | RG-6013; RO-5534262; ACE-910 | Approved | Chugai Pharmaceutical Co Ltd | 舒友立乐, Hemlibra | United States | Hemophilia A | Genentech Inc | 2017-11-16 | Hemophilia A; Hemorrhage; von Willebrand Disease, Type 3 | Details |
| Human Coagulation Factors IX and X (CSL Behring) | Approved | Csl Behring Llc | Factor X P Behring | Hemophilia B | Details | |||||
| Eptacog alfa biosimilar (AryoGen Biopharma) | Approved | Aryogen Biopharma | Iran | Factor VII Deficiency; Hemophilia A; Hemophilia B; Thrombasthenia | Aryogen Biopharma | 2014-01-01 | Factor VII Deficiency; Hemophilia A; Hemophilia B; Thrombasthenia | Details | ||
| Factor IX complex (Grifols) | Approved | Grifols Sa | Profilnine | United States | Hemophilia B | null | 1981-07-21 | Hemophilia B; Intracranial Hemorrhages | Details | |
| Eptacog beta | LR-769; rhFVIIa | Approved | Lfb Biotechnologies Sas, Revo Biologics Inc | Sevenfact | United States | Hemophilia A; Hemophilia B | Lfb Biotechnologies Sas | 2020-04-01 | Hemophilia A; Hemophilia B; Thrombasthenia | Details |
| Human prothrombin complex (Octapharma) | Approved | Octapharma | Ocplex, Octaplex, Pronativ | Germany | Hemorrhage | Octapharma | 2003-03-14 | Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details | |
| Eptacog alfa biosimilar (International Biotech Center Generium) | GNR-001 | Approved | International Biotech Center Generium | Russian Federation | Hemophilia A | International Biotech Center Generium | 2015-01-01 | Hemophilia A | Details | |
| Human prothrombin complex (LFB) | Approved | Lfb Biotechnologies Sas | KANOKAD | France | Hemorrhage | Lfb Biotechnologies Sas | 2008-09-01 | Hemorrhage | Details | |
| Human prothrombin complex (Tonrol Biopharmaceuticals) | Approved | Tonrol Bio-Pharmaceutical Co Ltd | ProthoRAAS | Mainland China | Hemorrhage | Shanghai Raas Blood Products Co Ltd | 1996-01-01 | Hemophilia B; Hemorrhage | Details | |
| Human prothrombin complex (ShenzhenWeiguang Biological Products) | Approved | Shenzhen Weiguang Biological Products Co Ltd | Mainland China | Hemorrhage | Shenzhen Weiguang Biological Products Co Ltd | 2024-05-21 | Hemophilia B; Hemorrhage | Details | ||
| Human prothrombin complex (Guangdong Shuanglin) | Approved | Guangdong Shuanglin Bio-Pharmaceutical Co Ltd | Mainland China | Hemophilia B | Guangdong Shuanglin Bio-Pharmaceutical Co Ltd | 2023-05-12 | Hemophilia B | Details | ||
| Dalnacogene Ponparvovec | BBM-H901 | Approved | Belef BioMed (Shanghai) Co Ltd | 信玖凝 | Mainland China | Hemophilia B | Shanghai Belief-Delivery BioMed Co Ltd | 2025-04-08 | Hemophilia B | Details |
| Human prothrombin complex (Shanghai Xinxing) | Approved | Shanghai Xinxing Medicine Co Ltd | Mainland China | Hemorrhage | Shanghai Xinxing Medicine Co Ltd | 1997-01-01 | Hemorrhage | Details | ||
| Human prothrombin complex (Sinopharm Shanghai Plasma) | Approved | Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd | Mainland China | Hemorrhage | Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd | 1997-01-01 | Hemorrhage | Details | ||
| Human prothrombin complex (Boya Bio-Pharmaceutical) | Approved | Boya Bio-Pharmaceutical Group Co Ltd | Mainland China | Hemorrhage | Boya Bio-Pharmaceutical Group Co Ltd | 2020-12-02 | Hemophilia B; Hemorrhage | Details | ||
| Human prothrombin complex (Guangdong Wellen) | Approved | Guangdong Wellen Pharmaceutical Co Ltd | Mainland China | Hemorrhage | Guangdong Wellen Pharmaceutical Co Ltd | 2020-10-21 | Hemophilia B; Hemorrhage | Details | ||
| Human prothrombin complex (Lanzhou Lansheng Blood Products) | Approved | Lanzhou Lansheng Blood Products Co Ltd | Mainland China | Hemophilia B | Lanzhou Lansheng Blood Products Co Ltd | 2024-09-26 | Hemophilia B | Details | ||
| Recombinant human coagulation factor VIIa N01 (Nanjing Chia-Tai Tianqing) | TQG-203 | Approved | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Mainland China | Hemophilia A; Hemophilia B | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | 2025-06-30 | Hemophilia A; Hemophilia B | Details | |
| Factor IX (Octapharma ) | Approved | Octapharma | Octanine F 100 I.E./ml Pulver und Lösungsmittel zur Herstellung einer Injektionslösung, OCTANINE F 500 UI pulbere şi solvent pentru soluţie perfuzabilă, octanine 500TV milteliai ir tirpiklis injekciniam tirpalui, Octanine 100 IU/ml, OCTANINE, OCTANINE 500 NE por és oldószer oldatos injekcióhoz, Octanine 500 SV pulveris un šķīdinātājs injekciju šķīduma pagatavošanai, Octanine F 500 | EU | Hemophilia B | Octapharma | 2001-12-23 | Hemophilia B | Details | |
| Human prothrombin complex(Chengdu Rongsheng Pharmaceuticals) | Approved | Chengdu Rongsheng Pharmaceuticals Co Ltd | Mainland China | Coagulation Protein Disorders | Chengdu Rongsheng Pharmaceuticals Co Ltd | 2020-12-15 | Coagulation Protein Disorders; Hemophilia B | Details | ||
| Human prothrombin complex(Hebei Daan Pharmaceutical) | Approved | Hebei Daan Pharmaceutical Co Ltd | Mainland China | Hemorrhage | Hebei Daan Pharmaceutical Co Ltd | 2020-01-01 | Hemophilia B; Hemorrhage | Details | ||
| Prothrombin complex concentrat (Taibang Biological Products) | Approved | Shandong Taibang Biological Products Co Ltd | Mainland China | Hemorrhage | Shandong Taibang Biological Products Co Ltd | 2014-09-30 | Antithrombin III Deficiency; Hemorrhage | Details | ||
| Human prothrombin complex (Hualan Biological Engineering) | Approved | Hualan Ankang Biotechnology Co Ltd | Mainland China | Factor X Deficiency; Blood Coagulation Disorders | Hualan Biological Engineering Inc | 1999-01-01 | Blood Coagulation Disorders; Factor X Deficiency; Hemophilia B | Details | ||
| Human prothrombin complex concentrate (Shanxi Kangbao Biological Products) | Approved | Shanxi Kangbao Biological Product Co Ltd | Mainland China | Hemorrhage | Shanxi Kangbao Biological Product Co Ltd | 2019-09-17 | Hemophilia B; Hemorrhage | Details |
- Informations sur la molécule
- Liste de produits
- Informations sur les médicaments commercialisés
- Informations sur les médicaments cliniques
Partager vers :